Inositol — Stack & Timing
Educational timing and stacking information based on how Inositol has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how Inositol has been studied and commonly used.
Commonly studied timing
Inositol is typically administered in divided doses throughout the day in research settings to maintain consistent levels; taking it with meals may help reduce gastrointestinal side effects such as nausea commonly reported at higher doses.
Dose ranges used in studies
Doses in PCOS and gestational diabetes research typically range from 2,000–4,000 mg/day of myo-inositol, while psychiatric studies (OCD, panic disorder, bipolar) have used up to 18,000 mg/day in divided doses; the D-chiro-inositol form is studied at much lower doses and the optimal myo- to D-chiro ratio (e.g., 40:1) varies by indication.
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Combined with myo-inositol (typically at a 40:1 ratio) for PCOS management to address insulin signaling and hormonal balance across different tissue compartments
Co-supplemented during pregnancy-related use (e.g., gestational diabetes prevention) as both nutrients support early fetal development and metabolic health
Combined in Hashimoto's thyroiditis contexts where inositol may support thyroid function and selenium has established evidence for reducing thyroid antibodies
Potentially combined for mood-related or metabolic indications given complementary mechanisms; omega-3s have WFSBP/CANMAT guideline support for psychiatric conditions where inositol is also explored
Safety & interactions
Inositol is generally well-tolerated; the most common adverse effects are gastrointestinal (nausea, flatulence, diarrhea) and tend to occur at higher doses (≥12–18 g/day). It appears safe in pregnancy at doses studied for gestational diabetes prevention, but use during pregnancy should only occur under medical supervision.
- •May have additive effects with insulin or oral hypoglycemic agents due to insulin-sensitizing properties — blood glucose monitoring is advisable
- •Possible interaction with lithium in bipolar disorder contexts, as inositol depletion is part of lithium's proposed mechanism — combined use should be medically supervised
- •May theoretically interact with SSRIs or other serotonergic agents when used at high psychiatric doses, though direct interaction data are limited
Individuals with bipolar disorder should use caution at high doses without psychiatric supervision, as evidence is mixed and interaction with mood-stabilizing medications is possible. Pregnant individuals should consult a healthcare provider before use despite generally favorable safety data. Those with known hypersensitivity to inositol should avoid it.